Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds

Medical THC and CBD formulation significantly reduces late-life dementia agitation

In a first-of-its-kind clinical trial, U.S. researchers have found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana – THC and CBD – had significantly less agitation compared to people who received a placebo.

MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer's Disease and Dementia

Results presented by the LiBBY study team at the Alzheimer’s Association International Conference (“AAIC”) demonstrated statistically significant improvements in agitation symptoms compared with placebo. The LiBBY study evaluated MediPharm Labs’ proprietary oral cannabinoid formulation, developed and supplied exclusively by MediPharm Labs for use in the trial. TORONTO, July 14, 2026 (GLOBE NEWSWIRE) — MediPharm Labs […]

Medical cannabis may help agitation in dementia, study suggests

Patients with advanced dementia near the end of their lives experienced an easing of symptoms after receiving THC/CBD treatment

Elderly dementia sufferers less agitated after marijuana treatment, study finds

Medications such as morphine, Valium and Haldol have been found to have limited effectiveness in treating dementia-related agitation

Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds

In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana—THC and CBD—had significantly less agitation than people who received a placebo.

Purified THC/CBD Oil Dramatically Lowers Dementia Agitation

A new study demonstrates that a specialized oral THC/CBD medical oil formulation significantly and rapidly reduces end-of-life agitation in late-stage dementia patients.